Today we celebrate #worldhepatitisday and shine a light on the millions of people battling #hepatitisb around the globe. Join us and @Hep_Alliance in raising awareness for the fight against #hbv.
VBI Vaccines
Prior to its bankruptcy proceedings in 2024, VBI Vaccines faced significant operational, financial, and organizational challenges, which many former employees attributed to poor leadership and ineffective management decisions. Critics of the company pointed to inconsistent strategic direction, questionable resource allocation, and repeated restructuring efforts that negatively affected morale and long-term stability. Some former staff members argued that scientific innovation, employee development, and retention were not adequately prioritized despite the company’s strong scientific potential. Management including CEO, CFO, CSO, and senior team was also criticized for being disconnected from employees’ concerns and for fostering a culture in which staff felt undervalued and unsupported during periods of financial difficulty and organizational change. More on Wikipedia
-
VBI Vaccines Inc.
@VBIVaccines
-
VBI Vaccines Inc.
@VBIVaccines
#dyk our cancer vaccine candidate, VBI-1901, is an immunotherapy? Learn more about how VBI is harnessing the power of the body’s innate immune response to fight #glioblastoma this #cancerimmunotherapymonth: www.vbivaccines.com/our-pipeline/
-
VBI Vaccines Inc.
@VBIVaccines
With few approved treatment options, we’re working to change the odds for #glioblastoma patients.
ICYMI, VBI is presenting new and encouraging data from our VBI-1901 program in recurrent #gbm at #asco24 on Saturday, June 1. Read more here: www.vbivaccines.com/press-releases/vbi-vaccines-announces… #btam -
VBI Vaccines Inc.
@VBIVaccines
Today, we announced new & encouraging data from our Phase 2b study of VBI-1901 in recurrent #glioblastoma will be presented at #asco24 this Saturday. We look forward to advancing this program and continuing our fight against #gbm. Read full details here: www.vbivaccines.com/press-releases/vbi-vaccines-announces…
-
VBI Vaccines Inc.
@VBIVaccines
This #hepatitisawarenessmonth, we are highlighting the millions of individuals infected with #hbv. Prevention is possible through testing and vaccination. Learn more about the @CDC’s adult hepatitis B vaccination guidelines here: www.cdc.gov/hepatitis-b/vaccination/index.html
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to share that new interim data from our randomized, controlled Phase 2b study of VBI-1901 in recurrent #glioblastoma will be presented at #asco24.
Learn more here: www.vbivaccines.com/press-releases/vbi-vaccines-announces… @ASCO #gbm #braintumorawarenessmonth -
VBI Vaccines Inc.
@VBIVaccines
#dyk that hepatitis B is a vaccine-preventable liver disease and that the @cdchep recommends all adults ages 19-59 should be vaccinated against #hbv? May is #hepatitisawarenessmonth – learn the ABCs of Viral Hepatitis here: www.cdc.gov/hepatitis/awareness/HepatitisABCs.htm
-
VBI Vaccines Inc.
@VBIVaccines
This #braintumorawarenessmonth, we support the brain tumor community and shine a light on the impact these difficult diagnoses have on patients, families, and caretakers. Help us raise awareness as we #gograyinmay
-
VBI Vaccines Inc.
@VBIVaccines
The @cdchep estimates that as many as 2.2 million people are chronically infected with #hbv in the U.S., but only 30% of adults are fully vaccinated. Understand the risks of infection and know your vaccination options this #adulthepbvaxday.
-
VBI Vaccines Inc.
@VBIVaccines
VBI celebrates vaccination as the frontline of protection against disease & as a cost-effective public health intervention. Read @OHENews' report on the health & socio-economic benefits of immunization programs here: www.ifpma.org/initiatives/vaccinesforlife/
#worldimmunizationweek #vaccinesforlife -
VBI Vaccines Inc.
@VBIVaccines
This morning, we announced full year 2023 financial results in addition to recent business highlights and upcoming milestones. Read the full update here: www.vbivaccines.com/press-releases/vbi-vaccines-reports-f… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, David E. Anderson, PhD, VBI's CSO, presented encouraging early tumor response data from the Phase 2b study of VBI-1901 in recurrent #gbm at @vaccinenation's World Vaccine Congress 2024. Read more about the data here: www.vbivaccines.com/press-releases/vbi-vaccines-presents-… #wvcdc
-
VBI Vaccines Inc.
@VBIVaccines
We are grateful to announce an expanded collaboration with the Canadian government, supported by CAD$28 million funding remaining under our original agreement. We look forward to continuing our partnership to accelerate the development of our MLE platform. www.vbivaccines.com/press-releases/vbi-vaccines-announces…
-
VBI Vaccines Inc.
@VBIVaccines
Though a rare disease, #glioblastoma accounts for nearly half of all malignant brain tumors with an estimated 12,000 people diagnosed annually in the U.S. Today and every day we strive to provide new treatment options for patients with #gbm.
#rarediseaseday $VBIV @rarediseases -
VBI Vaccines Inc.
@VBIVaccines
$VBIV in the News: Today we shared interim Phase 1 results for VBI-2901 – representing the first data in the field from a pan-coronavirus vaccine candidate to show broadened & durable immune responses against both human & animal coronaviruses #covid19 on.mktw.net/48wDQgf
-
VBI Vaccines Inc.
@VBIVaccines
We are proud to support the global public health battle against #hepb through our commitment to address both prevention & treatment. Together with @Hep_Alliance, join us in raising awareness this #worldhepatitisday and learn more here: www.worldhepatitisday.org #hepcantwait
-
VBI Vaccines Inc.
@VBIVaccines
This #gbmday, we are proud to partner with @NBTStweets to raise awareness for patients with this aggressive cancer who need additional treatment options. $VBIV #glioblastoma
-
VBI Vaccines Inc.
@VBIVaccines
Today we announced the launch of our 3-antigen prophylactic #hbv vaccine in the Netherlands & Belgium through our partnership with Valneva. Together with our partners, we continue to take important steps in the public health battle against #hepb worldwide $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
ICYMI: Jeff Baxter, CEO, & David E Anderson, CSO, recently sat down with analyst Steven Seedhouse, Ph.D., of Raymond James and Associates to discuss encouraging initial Phase 2 data from our #hbv immunotherapeutic candidate, VBI-2601. Access the replay: www.vbivaccines.com/press-releases/vbi-vaccines-to-discus…
-
VBI Vaccines Inc.
@VBIVaccines
Tune in today at 1pm ET to listen as Jeff Baxter, President & CEO, and David E. Anderson, Chief Scientific Officer, discuss our #hbv portfolio with covering analyst, Steven Seedhouse, Ph.D., of Raymond James & Associates, Inc. Access the link here: www.vbivaccines.com/press-releases/vbi-vaccines-to-discus… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
#didyouknow – according to the CDC, 25% of chronic #hbv infections develop into liver cancer? We are proud to partner with @VaccinesEurope this #worldcancerday to shine a light on the importance of supporting both prevention and treatment of this vaccine-preventable disease
-
VBI Vaccines Inc.
@VBIVaccines
We are happy to share that our #hbv vaccine, PreHevbrio™ [3-Antigen Hepatitis B Vaccine (Recombinant)] is now approved by Health Canada, marking the fourth regulatory approval for this vaccine in the past year. Learn more: www.vbivaccines.com/press-releases/health-canada-approval… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today we shared updated tumor response, clinical response, & biomarker data from our Phase 1/2a study of VBI-1901, our #cancervaccine immunotherapeutic candidate in recurrent #gbm, from our poster at the SNO Annual Meeting. Click here learn more: www.vbivaccines.com/press-releases/vbi-1901-phase-1-2a-da… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Our CEO, Jeff Baxter, and our CFO, Christopher McNulty, are set to participate in two analyst-led fireside chats this week at the Guggenheim 4th Annual Immunology and Neurology Day and the Jefferies London Healthcare Conference. Tune in here: www.vbivaccines.com/investors/events-and-presentations/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
ICYMI: Jeff Baxter, CEO, and David E Anderson, CSO, will participate in an analyst-led fireside chat at the H.C. Wainwright Hepatitis B Conference today (Oct. 18) at 9am ET. Access the webcast link here: journey.ct.events/view/3e9eb344-7443-4cd4-95af-fbd993a0fcc7 $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
Today we announced a new collaboration with @Agenus_bio in primary #gbm as part of the INSIGhT adaptive platform study. We anticipate initiating enrollment around year-end 2022 & look forward to sharing data from this clinical combination. Read more: bwnews.pr/3EEAnQe $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today we shared the initiation of our first human study of VBI-2901, our multivalent coronavirus vaccine candidate targeting COVID-19, SARS, and MERS. We look forward to sharing initial data, expected mid-year 2023. Read more: www.vbivaccines.com/press-releases/initiation-phase-1-stu… #covid19 $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We announced this morning that we have entered into an upsized and refinanced debt agreement with our partners @K2HVenture, which, upon closing, adds $20 million of non-dilutive funding to our balance sheet. Read more here: www.vbivaccines.com/press-releases/100-million-debt-facil… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are excited to announce our partnership with Valneva for the commercial launch of PreHevbri [Hepatitis B vaccine (recombinant, adsorbed)] in certain European countries. We look forward to working together to support HCPs in their battle against hep B. www.vbivaccines.com/press-releases/valneva-partnership/
-
VBI Vaccines Inc.
@VBIVaccines
#icymi: PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] has been recognized as a 2022 #prixgalien USA “Best Biotechnology Product” nominee. $VBIV is honored to be considered among this year’s nominees. Learn more about the Prix Galien awards here: www.prnewswire.com/news-releases/the-galien-foundation-an…
-
VBI Vaccines Inc.
@VBIVaccines
This morning, we shared second quarter 2022 financial results and highlighted recent developments in addition to upcoming milestones. Read the full update here: www.vbivaccines.com/press-releases/q2-2022/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
GBM median overall survival rates remain too low – FDA recently granted Orphan Drug Designation to our vaccine candidate, VBI-1901, and we are working hard to provide a new treatment option for patients with this devastating disease. #gbmday $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today is #gbmday. We are proud to partner with @NBTStweets to increase education and awareness for glioblastoma patients and their caregivers. Help us shine a light on this complex, aggressive, and underserved brain tumor. $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We announced today that the FDA has granted us Orphan Drug Designation for our cancer vaccine immunotherapeutic candidate, VBI-1901, for the treatment of glioblastoma. Read the full announcement here: www.vbivaccines.com/press-releases/fda-orphan-drug-design… $VBIV #gbm
-
VBI Vaccines Inc.
@VBIVaccines
We apologize for the technical difficulties experienced during our fireside chat today at the Jefferies Healthcare Conference. We are working with the Jefferies team to remedy the situation.
-
VBI Vaccines Inc.
@VBIVaccines
Jeff Baxter, CEO, will participate in an analyst-led fireside chat at 1:30pm ET on Wednesday, June 8 at the Jefferies Healthcare Conference. The chat will be moderated by Jefferies covering analyst Roger Song, M.D. Access the webcast link here: www.vbivaccines.com/press-releases/jefferies-2022/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
In case you missed it, today we shared encouraging new median overall survival & 18-month overall survival data from our ongoing study of VBI-1901 in recurrent #gbm from this year’s ASCO meeting. Read the full press release & access the poster here: www.vbivaccines.com/press-releases/gbm-asco-2022/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
May is #hepatitisawarenessmonth – help shine a light on the burden #hepb poses and learn about your vaccine options www.cdc.gov/mmwr/volumes/71/wr/mm7113a1.htm
NFID
@NFIDVaccines
Despite the availability of safe & effective #hepatitisb #vaccines, many adults remain unprotected. @cdchep recommends that all adults under age 60 #getvaccinated to help prevent #hepb. Learn more: www.nfid.org/hepatitis #hepatitisawarenessmonth
-
VBI Vaccines Inc.
@VBIVaccines
We shared first quarter 2022 financial results in addition to recent development highlights plus upcoming milestones this morning. Read the full update here: www.vbivaccines.com/press-releases/q1-2022/. $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
#hepb is a highly infectious, vaccine-preventable disease, yet approximately 75% of U.S. adults remain unvaccinated & at risk. Tomorrow marks National Adult Hepatitis B Vaccination Day – learn your vaccination status & discuss vaccine options with your healthcare provider. $VBIV
CDC Hepatitis
@cdchep
#hcps: over half of #hepatitisb cases reported in 2019 occurred among people 30-49 years old.
CDC now recommends UNIVERSAL vaccination of adults through age 59 against #hepb.
Learn more: www.cdc.gov/hepatitis/hbv/vaccadults.htm
#vaccineswork
@CDCMMWR -
VBI Vaccines Inc.
@VBIVaccines
VBI in the News: Our take on a pan-coronavirus vaccine approach was featured in a story by the AFP. We are committed to finding a solution for long-term protection against COVID-19 & coronaviruses, and look forward to initiating clinical studies of VBI-2901, expected this summer
AFP News Agency
@AFP
As vaccine makers rush to stamp out new #covid19 variants, some scientists have set their sights higher, aiming for a universal coronavirus vaccine that could tackle any future strains and possibly even stave off another pandemic
www.yahoo.com/news/quest-universal-coronavirus-vaccine-09… -
VBI Vaccines Inc.
@VBIVaccines
Today we announced updated data and guidance for our enveloped virus-like particle (eVLP) coronavirus development program. Click here for the full release: www.vbivaccines.com/press-releases/new-data-and-progress-… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to announce that our first FDA-approved product, PreHevbrio™ [Hepatitis B Vaccine (Recombinant)], is now available in the U.S. Learn More: www.vbivaccines.com/press-releases/prehevbrio-available/. $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
This morning, we announced fourth quarter and full year 2021 financial results in addition to recent achievements and upcoming milestones across our pipeline. Read the full update here: www.vbivaccines.com/press-releases/2021-results/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to share that our partner, Brii Bio, has initiated dosing in an additional Phase 2 study to evaluate VBI-2601 as an add-on therapy to potentially improve outcomes of standard-of-care treatment in chronic hepatitis B patients www.vbivaccines.com/press-releases/vbi-vaccines-announces… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to share that we filed our New Drug Submission (NDS) for our 3-antigen prophylactic HBV vaccine candidate to Health Canada. Learn more: www.vbivaccines.com/press-releases/vbi-vaccines-announces… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are excited to share that Dr. David E Anderson, VBI’s CSO, will present encouraging new 12-month and 18-month overall survival data from our ongoing Phase 2a study of VBI-1901 in recurrent glioblastoma (#gbm) patients. Learn More: www.vbivaccines.com/glioblastoma-gbm/world-vaccine-immuno… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to announce that our first product, PreHevbrio™ [Hepatitis B Vaccine (Recombinant)], is now #fda approved. Learn More: www.vbivaccines.com/press-releases/prehevbrio-approval/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Jeff Baxter, CEO, will participate in an analyst-led fireside chat on Wednesday, November 17 at the Jefferies London Healthcare Conference. The chat will be moderated by Jefferies covering analyst Kelechi Chikere, Ph.D. Access the webcast link here: www.vbivaccines.com/press-releases/jefferies-london-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
This morning, we announced third quarter 2021 financial results in addition to recent development highlights and upcoming catalysts across our vaccine pipeline. Read the full update here: www.vbivaccines.com/press-releases/q3-2021-results/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, in a move to step up the fight against #hepb, the #cdc’s Advisory Committee on Immunization Practices, #acip, unanimously passed a universal HepB vaccination recommendation for all unvaccinated adults age 19-59, and for adults age 60+ with risk factors for infection. $VBIV
Hep B United
@HepBUnited
Today, the CDC's Advisory Committee on Immunization Practices will be voting to decide all adults should be vaccinated for #hepatitis B. Tune in to the discussion with this link: video.ibm.com/channel/VWBXKBR8af4
➡️ 4:10 PM ET: Hepatitis B Vote on universal adult #hbv vaccination -
VBI Vaccines Inc.
@VBIVaccines
We are pleased to share that results from CONSTANT, a pivotal Phase 3 study of our prophylactic 3-antigen hepatitis B vaccine candidate, have been published in JAMA Network Open. Click here to read more and to access the full manuscript: www.vbivaccines.com/press-releases/publication-of-constan… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
Members of VBI’s management team will present at the upcoming Guggenheim 2nd Annual Vaccines & Infectious Disease Conference (Oct. 5) & the H.C. Wainwright 2nd Annual HBV Conference (Oct. 13). Click for more information, including webcast details: www.vbivaccines.com/press-releases/october-conferences/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Tune into our live conference call at 8:30am ET this morning to hear CEO, Jeff Baxter, and CSO, David Anderson, discuss new preclinical data and VBI’s COVID-19 and betacoronavirus development strategy. www.vbivaccines.com/press-releases/initiation-of-vbi-2905… #covid19 $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced second quarter 2021 financial results in addition to recent pipeline development highlights and upcoming catalysts throughout the remainder of the year. Read the full update here: www.vbivaccines.com/press-releases/q2-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are honored to help support the @HepBFoundation’s #300mr campaign this World Hepatitis Day. Join us in raising awareness, and protect yourself and your loved ones by getting tested and knowing the risks of #hbv infection www.hepb.org/what-is-hepatitis-b/what-is-hepb/ #300mr #worldhepatitisday $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are honored to support @NBTStweets in another successful #gbmday – in parallel we are working to advance our GBM immunotherapeutic candidate, VBI-1901, with the goal of contributing a meaningful treatment option to patients who currently havevery few. $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today is #gbmday. Join us and our partners @NBTStweets as we raise awareness and support for GBM patients and their caregivers. braintumor.org/gbmday $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
July 21 is Glioblastoma Awareness Day. As a proud partner of @NBTStweets, VBI is working to help address this highly complex and devastating brain cancer. braintumor.org/gbmday #gbmday $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are excited to welcome Linda Bain, CFO of @codiakbio, to our Board of Directors, bringing with her more than two decades of extensive business and financial strategy experience and a deep knowledge of the life sciences industry. www.vbivaccines.com/press-releases/linda-bain/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today we reported the AMA issuance of a unique CPT code for a 3-antigen HBV vaccine. Pending FDA approval, VBI’s 3-antigen HBV vaccine candidate will be billed under this code, differentiating it from other single-antigen HBV vaccines. Read more: www.vbivaccines.com/press-releases/new-cpt-code/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
This morning we announced positive data from our Phase 1 study of VBI-2902, establishing a robust human proof-of-concept for the eVLP platform against COVID-19. Tune in to our conference call and webcast at 8:30am ET – learn more: www.vbivaccines.com/press-releases/covid-19-vaccine-phase… $VBIV #covid19
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced upcoming poster presentations of data from the Phase 3 clinical program of our prophylactic 3-antigen hep B vaccine candidate at the @GlobalHepSummit 2020/2021, & the @AmDiabetesAssn's Virtual 81st Scientific Sessions. Learn more: www.vbivaccines.com/press-releases/upcoming-scientific-co… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced that 2 abstracts featuring data from our prophylactic & therapeutic hepatitis B (#hbv) candidates have been accepted for poster presentation at The Digital International Liver Congress 2021 (ILC), the Annual Meeting of @EASLnews www.vbivaccines.com/press-releases/easl-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We announced today that the FDA has granted us Fast Track Designation for our cancer vaccine immunotherapeutic candidate, VBI-1901, for the treatment of recurrent glioblastoma (#gbm) patients with first tumor recurrence. Read more here: www.vbivaccines.com/press-releases/vbi-1901-gbm-fda-fast-… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Members of VBI’s management team will present at the upcoming Jefferies Virtual Healthcare Conference (June 3) and the Raymond James Human Health Innovation Conference (June 18). Click the link for more information, including webcast details: www.vbivaccines.com/press-releases/upcoming-conferences-m… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Following the recent achievement of clinical milestones related to our immunotherapeutic HBV & GBM candidates, we announced an agreement to draw down a $12 million second tranche under our existing debt financing facility with K2 HealthVentures. www.vbivaccines.com/press-releases/may-2021-debt-financing/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today we announced additional tumor response & overall survival data from the Phase 2a study of VBI-1901 in recurrent GBM patients, to be presented in our upcoming poster at the 2021 @ASCO Meeting. Find the topline data highlights here: www.vbivaccines.com/press-releases/asco-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
This Hepatitis Testing Day, make sure you know the facts about the risks of #hepb infection. Get tested to protect yourself and your loved ones. www.cdc.gov/hepatitis/awareness/HepatitisABCs.htm #hepaware2021
-
VBI Vaccines Inc.
@VBIVaccines
May is Hepatitis Awareness Month. Learn the ABC's of viral #hepatitis to find out if you should get tested and/or vaccinated. Check out @cdchep's toolkit to learn more: www.cdc.gov/hepatitis/awareness/HepatitisABCs.htm
-
VBI Vaccines Inc.
@VBIVaccines
Results from the PROTECT Phase 3 study of our 3-antigen hepatitis B vaccine have been published in @TheLancetInfDis. Learn more: www.vbivaccines.com/press-releases/lancet-protect-phase-3… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced first quarter 2021 financial results, recent program achievements, and upcoming milestones across our vaccine pipeline. Find the full update here: www.vbivaccines.com/press-releases/q1-2021/ #vbiv
-
VBI Vaccines Inc.
@VBIVaccines
ICYMI, our #pancoronavirus vaccination approach was recently featured in a story by @Forbes' @leah_rosenbaum. Our team is working hard to be part of the solution for the long-term control of known and emerging #coronaviruses. Full story here: www.forbes.com/sites/leahrosenbaum/2021/05/04/these-compa… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced upcoming oral and poster presentations of data from the PROTECT and CONSTANT pivotal Phase 3 studies evaluating VBI’s 3-antigen prophylactic hepatitis B vaccine candidate at the Canadian Liver Meeting 2021. Learn more: www.vbivaccines.com/press-releases/liver-meeting-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
With Hepatitis Awareness Month kicking off tomorrow, join us in recognizing this National Adult Hepatitis B Vaccination Awareness Day by learning your vaccination status and the risks of infection, and by making sure you are protected against #hepb
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced the publication of preclinical & challenge study data from our COVID-19 eVLP vaccine candidate, VBI-2902, available on preprint server @bioRxiv, demonstrating a highly potent & focused nAb response and conferred protective benefit www.vbivaccines.com/press-releases/vbi-2902-preclinical-a… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Jeff Baxter, CEO, and David E. Anderson, Ph.D., CSO, will discuss VBI’s coronavirus vaccine candidates in an analyst-led biotech investor summit hosted by National Securities Corporation tomorrow, April 28 at 1:30 PM ET. Access the webcast link here: www.vbivaccines.com/press-releases/national-securities-co… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced the upcoming presentation of Phase 3 immunogenicity and safety data from VBI’s 3-antigen prophylactic hepatitis B #vaccine candidate at the @NFIDvaccines Annual Conference on Vaccinology Research on April 27. Learn more: www.vbivaccines.com/press-releases/2021-annual-conference… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Patient dosing is underway in a Phase 2 study combining BRII-835 (VIR-2218), @vir_biotech's investigational HBV-targeting siRNA, and BRII-179 (VBI-2601), VBI’s HBV immunotherapeutic candidate, as a potential functional cure for chronic #hbv. www.vbivaccines.com/press-releases/brii-vir-vbi-phase-2-h… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Phase 1b/2a data of VBI-2601 (BRII-179) #hepatitisb immunotherapeutic candidate enables selection of high-dose of VBI-2601 for a Phase 2 combo study with BRII-835 (VIR-2218), conducted by Brii Bio - patient dosing expected to initiate early Q2 2021. www.vbivaccines.com/press-releases/hepatitis-b-immunother… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Jeff Baxter, CEO, and David E. Anderson, Ph.D., CSO, will participate in a fireside chat with covering analyst Leland Gershell, M.D., Ph.D., at the Oppenheimer 31st Annual Healthcare Conference. Access the webcast link here: www.vbivaccines.com/press-releases/oppenheimer-2021/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Just Announced: Our partnership with @CEPIvaccines will provide up to $33M to develop our eVLP candidates against #covid19 variants of concern. We look forward to working with CEPI, who share our commitment to the long-term protection against coronaviruses www.vbivaccines.com/press-releases/cepi-collaboration/
-
VBI Vaccines Inc.
@VBIVaccines
We are excited to begin the clinical assessment of our eVLP approach to vaccination against #coronaviruses with this adaptive Phase 1/2 study. We look forward to sharing initial data expected by the end of Q2 2021, subject to rate of enrollment. www.vbivaccines.com/press-releases/enrollment-in-phase-1-… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Today, we announced fourth quarter and full year 2020 financial results along with an annual note from our CEO, Jeff Baxter. Read more for a recap of recent program highlights and an outlook on the catalyst-rich year ahead for VBI: www.vbivaccines.com/press-releases/q4-and-2020-results/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Tomorrow: Jeff Baxter, CEO, & David E. Anderson, Ph.D., CSO, will participate in a fireside chat with covering analyst Steven Seedhouse, Ph.D., at the Raymond James Annual Institutional Investors Conference. Access the webcast link here: www.vbivaccines.com/press-releases/vbi-vaccines-to-presen… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
“Scientists at VBI Vaccines were asking themselves a key question: Can a vaccine be created to deal with more than one kind of coronavirus?”
@globeandmail's @IvanSemeniuk on the potential role of #pancoronavirus vaccines in the fight against coronaviruses tgam.ca/3qsG21Q -
VBI Vaccines Inc.
@VBIVaccines
The @nytimes @carlzimmer highlight our work to develop a #pancoronavirus vaccine that may be able to potentially protect against known & emerging COVID-19 variants & other coronaviruses. We're committed to being part of the solution to the ongoing pandemic www.nytimes.com/2021/02/09/health/universal-coronavirus-v…
-
VBI Vaccines Inc.
@VBIVaccines
We are pleased to announce that the FDA has accepted the filing of our BLA for our 3-antigen prophylactic hepatitis B vaccine candidate, and has set a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2021. www.vbivaccines.com/wire/fda-bla-filing-hep-b-vaccine/ $VBIV #hbv #vaccines
-
VBI Vaccines Inc.
@VBIVaccines
Coronavirus vaccine program progress: Positive new hamster challenge data announced, first clinical study of VBI-2902 (monovalent, COVID-19) expected to begin Q1 2021. Read more here: www.vbivaccines.com/wire/coronavirus-vaccine-program-update/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
We are proud to announce that results from a Phase 4 study of our 3-antigen #hepatitisb vaccine have been published in the journal Vaccine. Read to learn more: www.vbivaccines.com/wire/results-of-phase-4-hepatitis-b-s… $VBIV #vaccines #hbv
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines announced today the European Medicines Agency (EMA) approval of our Marketing Authorization Application (MAA) for our 3-antigen prophylactic hepatitis B vaccine candidate. Learn more: www.vbivaccines.com/wire/ema-acceptance-of-3-antigen-prop… #hbv $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
ICYMI: In Q1 2021, Brii Biosciences expects to initiate a Phase 2 study assessing our HBV immunotherapeutic, VBI-2601 (BRII-179), in combo with BRII-835 (VIR-2218), a novel RNAi therapeutic, as a potential functional cure for chronic HBV. Read on: www.briibio.com/news-202002.php
-
VBI Vaccines Inc.
@VBIVaccines
In case you missed it, members of VBI’s leadership team are set to discuss recent news and strategic outlook for its hepatitis B portfolio with covering analyst, Steven Seedhouse, Ph.D., during a fireside chat at 11:00AM ET today. Register here: raymondjames.zoom.us/webinar/register/WN_i-eY5EFpSAWiQwiA… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
Today, VBI Vaccines announced the company’s commercialization partnership with @SyneosHealth for VBI’s 3-antigen hepatitis B vaccine. Learn more: www.vbivaccines.com/wire/syneos-health-commercialization-… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
VBI’s leadership team will discuss recent news & strategic outlook for the Company’s hepatitis B portfolio with analyst Steven Seedhouse, PhD of Raymond James & Associates, Inc during a fireside chat at 11:00 AM ET on December 8. Register here: www.vbivaccines.com/wire/raymond-james-2020/ $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines announced today the submission of a Biologics License Application to the U.S. Food and Drug Administration (FDA) seeking approval of the Company’s 3-antigen prophylactic hepatitis B vaccine candidate. Learn more: www.vbivaccines.com/wire/hepatitis-b-vaccine-fda-bla-subm… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines announced today the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the company’s 3-antigen prophylactic hepatitis B vaccine candidate. Read more: www.vbivaccines.com/wire/hepatitis-b-vaccine-naa-ema-subm… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines announced today positive new Phase 2a (Part B) data from its ongoing Phase 1/2a study of VBI-1901, our cancer vaccine immunotherapeutic candidate in recurrent glioblastoma at @NeuroOnc. Learn more about the e-poster presentation: www.vbivaccines.com/wire/sno-2020-phase-2a-data/ $VBIV #gbm
-
VBI Vaccines Inc.
@VBIVaccines
Today, VBI Vaccines announced positive interim phase 1b/2a data for Hepatitis B immunotherapeutic in patients with chronic infection in collaboration with Brii Biosciences. Learn more: www.vbivaccines.com/wire/interim-phase-1b-2a-data-for-hep… $VBIV #hbv
-
VBI Vaccines Inc.
@VBIVaccines
Today VBI Vaccines will present data from one of the pivotal Phase 3 studies (PROTECT) evaluating Sci-B-Vac, our 3-antigen prophylactic hepatitis B (#hbv) vaccine, in an e-poster presentation at @AASLDtweets. Learn more: www.vbivaccines.com/wire/scibvac-liver-meeting-2020/ $VBIV #livermtg20
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines will present data from the company’s cancer vaccine immunotherapeutic candidate in recurrent #glioblastoma (GBM) at the Annual Meeting and Education Day of @NeuroOnc on Nov. 19-21. Learn more about the e-poster & Phase 1/2a study: www.vbivaccines.com/wire/sno-2020/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
This morning, VBI Vaccines announced third quarter 2020 financial results, recent pipeline program highlights, and upcoming milestones. Read more here: www.vbivaccines.com/wire/q3-2020-results-and-corporate-up… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines delivered two e-poster presentations at #idweek2020, featuring data from our Phase 3 clinical program evaluating Sci-B-Vac®, our 3-antigen prophylactic hepatitis B vaccine. View the e-posters and learn more about the data here: www.vbivaccines.com/wire/id-week-2020/ $VBIV #hepb
-
VBI Vaccines Inc.
@VBIVaccines
Our management team will discuss $VBIV's vaccine immunotherapeutic candidate for chronic #hepatitisb at the H.C. Wainwright HBV Mini-Conference. CEO Jeff Baxter & CSO Dave Anderson will participate in a fireside chat on October 20. Read more: www.vbivaccines.com/wire/h-c-wainwright-hbv-2020/
-
VBI Vaccines Inc.
@VBIVaccines
Today VBI announces the presentation of Phase 3 Sci-B-Vac® data, the company’s 3-antigen prophylactic #hepatitisb vaccine, at the American Association for the Study of Liver Diseases on November 13. Learn more about the @AASLDtweets e-poster: www.vbivaccines.com/wire/the-liver-meeting-2020/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Take a look at @GENbio’s recent story by @AlexWestchester who spoke with our CSO, Dave Anderson, about $VBIV's #coronavirus vaccine candidates, highlighting the potential advantages of our eVLP development approach.
Genetic Engineering & Biotechnology News
@GENbio
One #covid19 Shot, Two Approaches. .@VBIVaccines CSO discusses the company’s pair of prospects vs. the pandemic. Read more: www.genengnews.com/gen-edge/one-covid-19-shot-two-approac…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines is looking forward to presenting at the upcoming World Vaccine Congress (Sept. 28-Oct. 1) and #idweek2020 (Oct. 21-25). Learn more about our presentations: www.vbivaccines.com/wire/wvc-and-id-week-2020/ $VBIV #wvcusa
-
VBI Vaccines Inc. reposted
Invest Ottawa
@Invest_Ottawa
As the world waits anxiously for a #covid19 #vaccine, there is unprecedented collaboration across companies and governments to make it happen. @VBIvaccine CEO Jeff Baxter gives us an inside look at the process in this week’s episode of #investedpod
🔊: www.investottawa.ca -
VBI Vaccines Inc.
@VBIVaccines
Presented at #esmo20: VBI Vaccines announces additional biomarker data from ongoing Phase 1/2a study evaluating VBI-1901, the company’s cancer vaccine immunotherapeutic candidate in recurrent #glioblastoma (GBM) patients. Learn more about the data: www.vbivaccines.com/wire/esmo-2020-poster/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines will present data on the company’s cancer vaccine immunotherapeutic candidate in recurrent #glioblastoma (GBM) at #esmo20 via e-poster Sept. 17-21. Learn more about the presentation and Phase 1/2a study design: www.vbivaccines.com/wire/esmo-2020/ @myESMO $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
Our CEO, Jeff Baxter, joined host Shavonne Hasfal-McIntosh (@PinkRobotTO) on the @Invest_Ottawa podcast. Listen to learn more about #covid19 vaccine development, $VBIV's coronavirus program, and how companies are working together in unprecedented ways: podcasts.apple.com/us/podcast/invested-in-our-new-reality…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines delivered two presentations at @EASLnews’s virtual meeting featuring data from our Phase 3 program evaluating Sci-B-Vac®, the company’s tri-antigenic prophylactic #hepatitisb #vaccine. Click to read more about the data: www.vbivaccines.com/wire/easl-2020-presentations/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
“Many scientists see their ongoing vaccine work as part of a long game — one that the well-being of entire nations will depend on.”
Thank you @carlzimmer & @nytimes for highlighting our work. $VBIV is proud to be part of the #covid19 effort. www.nytimes.com/2020/08/27/health/covid-19-vaccines.html?… -
VBI Vaccines Inc.
@VBIVaccines
#breaking: VBI Vaccines announces preclinical data from its #coronavirus program and selects two vaccine candidates to advance into adaptive Phase 1/2 clinical study, pending regulatory approval. Click to read more: www.vbivaccines.com/wire/preclinical-coronavirus-data-can… $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines will present at @EASLnews’s virtual annual meeting on Aug. 27 & Aug. 29. Presentations will feature data from our Phase 3 program evaluating Sci-B-Vac®, the company’s tri-antigenic prophylactic #hepatitisb #vaccine. Read more: www.vbivaccines.com/wire/easl-2020/ $VBIV #ilc2020
-
VBI Vaccines Inc.
@VBIVaccines
Our CSO, Dr. David E. Anderson, talked with @HealthProRadio about $VBIV ’s #coronavirus #vaccine program and our pipeline, highlighting the potential for vaccines to be used against both infectious disease and oncology targets. Listen to learn more: healthprofessionalradio.com.au/vbi-vaccines-pan-coronavir…
-
VBI Vaccines Inc.
@VBIVaccines
In case you missed it: Yesterday, the Canadian Government announced major steps in treating & preventing #covid19, including up to a CAD$56 million award to fund $VBIV ’s #coronavirus program through Phase 2. Read the Canadian Gov.’s announcement here: www.canada.ca/en/innovation-science-economic-development/…
-
VBI Vaccines Inc.
@VBIVaccines
#breaking: VBI Vaccines announced today that it will receive up to CAD$ 56 million from the Canadian Government’s Strategic Innovation Fund to support the development of the company’s #coronavirus program through Phase 2 clinical studies. Read more: www.vbivaccines.com/wire/canadian-govt-coronavirus-award/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
On this #worldhepatitisday, learn more about the risks of viral hepatitis, spread awareness, and encourage prevention. Visit @cdchep and their online educational resources: www.cdc.gov/hepatitis/
-
VBI Vaccines Inc.
@VBIVaccines
Did you know that glioblastoma is the deadliest and most common malignant brain tumor? On this #gbmday, help us raise awareness and honor GBM patients and caregivers. Learn more @NBTStweets: braintumor.org/events/glioblastoma-awareness-day/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines is proud to support the second annual Glioblastoma (GBM) Awareness Day this Wednesday, July 22, hosted by @NBTStweets. Learn how to get involved or virtually participate in #gbmday: braintumor.org/events/glioblastoma-awareness-day/
-
VBI Vaccines Inc.
@VBIVaccines
In case you missed it: $VBIV presented data from our ongoing Phase 1/2a study in recurrent #glioblastoma at #aacr20 this week. Watch the video on our website to learn more: www.vbivaccines.com/wire/ #gbm
-
VBI Vaccines Inc.
@VBIVaccines
Tomorrow, June 23, VBI Vaccines will participate in the @BMO 2020 Prescription for Success Healthcare Conference.
Watch the webcast at 8:00-8:25 a.m. ET by visiting our Investors page. Webcast will be archived for 90 days: www.vbivaccines.com/investors/events-presentations/ $VBIV -
VBI Vaccines Inc.
@VBIVaccines
Today VBI Vaccines is presenting data from our Phase 1/2a study at the @AACR Annual Meeting. In the study, a promising biomarker strategy was identified for recurrent #glioblastoma. For more information, including e-poster: www.vbivaccines.com/wire/aacr-june-2020/ $VBIV #aacr20 #gbm
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines will present at the upcoming @RaymondJames Human Health Innovation Conference (June 18) and the @BMO 2020 Prescription for Success Healthcare Conference (June 23). Follow the link for more information, including webcast details: www.vbivaccines.com/wire/investor-conferences-june-2020/ $VBIV
-
VBI Vaccines Inc.
@VBIVaccines
As we close out Hepatitis Awareness Month, remember to learn your ABCs: Hep A, Hep B, and Hep C. These three types of hepatitis are all caused by different viruses and are spread in different ways. Follow the link to become #hepaware2020: www.cdc.gov/hepatitis/awareness/index.htm
-
VBI Vaccines Inc.
@VBIVaccines
“We are honored to have attracted some of the leading experts in public health & #vaccine commercialization. Their decades-long experience, expertise, & networks will be invaluable as we strive to support public health initiatives…”–Jeff Baxter, CEO $VBIV www.vbivaccines.com/wire/formation-of-commercial-advisory…
-
VBI Vaccines Inc.
@VBIVaccines
"This partnership with K2HV complements our recent $57.5 million equity raise, strengthening the financial position & flexibility of VBI as we advance our pipeline candidates through clinical & regulatory milestones…” – Jeff Baxter, CEO $VBIV. Read more: www.vbivaccines.com/wire/50-million-debt-financing-2020/
-
VBI Vaccines Inc.
@VBIVaccines
Millions of Americans have chronic viral hepatitis, and most don’t know they are infected. On this National Hepatitis Testing Day, encourage your loved ones to talk to their doctor, learn their status, and become #hepaware2020. For more information: www.cdc.gov/hepatitis/awareness/index.htm
-
VBI Vaccines Inc.
@VBIVaccines
Our CEO Jeff Baxter is participating in a panel about vaccine development today at 12:00pm EDT. Hosted by @LifeSciAdvisors, the panel will discuss the history of #vaccines, the various #covid19 approaches, and $VBIV ’s pan-coronavirus candidate. Register: lifescipartners.zoom.us/webinar/register/WN_2nWaY0dXRB68B…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to present at @AACR’s virtual annual meeting: our poster, available on June 22, will highlight immunologic, tumor response, and potentially-predictive biomarker data from our ongoing Phase 1/2a study in #gbm. Read more: www.vbivaccines.com/wire/aacr-2020/ $VBIV #aacr2020
-
VBI Vaccines Inc.
@VBIVaccines
This year, the importance of safe and effective vaccines is more apparent than ever. During the month of May, join us, @cdchep, and @HHS_ViralHep in educating ourselves and our communities about hepatitis testing and vaccination. Learn more: www.cdc.gov/hepatitis/hbv/hbvfaq.htm #hepaware2020
-
VBI Vaccines Inc.
@VBIVaccines
Today @VBIVaccines announced the pricing of a $ 50 million underwritten public offering of its common shares. $VBIV plans to use the proceeds to support the development and advancement of its pipeline. The offering is expected to close on April 24, 2020. www.vbivaccines.com/wire/offering-pricing-april-2020/
-
VBI Vaccines Inc.
@VBIVaccines
#breaking: VBI Vaccines announces today a collaboration with the National Research Council of Canada (@NRC_CNRC) to develop a pan-coronavirus vaccine candidate, targeting #covid19, #sars & #mers, using $VBIV ’s eVLP platform technology. bwnews.pr/39yuUHq
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: $VBIV) announces overall survival benefit for vaccine responders in Part A of ongoing Phase 1/2a study in recurrent #gbm patients www.vbivaccines.com/wire/gbm-gsk-phase1-2a-study-update/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: $VBIV) doses first recurrent #gbm patient in Phase 2a study of cancer vaccine candidate, VBI-1901, in combination with @GSK's effective, proprietary AS01B adjuvant system www.vbivaccines.com/wire/dosing-of-first-gbm-patient-in-g…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces positive top-line results from 2nd pivotal Phase 3 study of Sci-B-Vac® – the study met both the primary and secondary endpoints. www.vbivaccines.com/wire/sci-b-vac-second-phase-3-study/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) presents early GBM tumor response and immunologic data from Part B of the ongoing Phase 1/2a study of VBI-1901 at the #sno19 annual meeting www.vbivaccines.com/wire/gbm-tumor-response-data-sno-2019/ #glioblastoma #immunooncology
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces initiation of dosing in Phase 1b/2a study in patients with chronic #hepatitisb infection as part of collaboration with Brii Biosciences www.vbivaccines.com/wire/gbm-part-b-data-sno-2019/
-
VBI Vaccines Inc.
@VBIVaccines
Great #livermtg19 Hepatitis Debrief by Dr Marc Ghany, NIDDK, NIH, featuring Sci-B-Vac’s ability to protect difficult-to-treat populations such as diabetics, those who are obese, smokers, & older adults. We're honored Dr Ghany featured our PROTECT data in his debrief! @AASLDtweets
-
VBI Vaccines Inc.
@VBIVaccines
AASLD 2019: Check out this @FierceBiotech article highlighting positive Sci-B-Vac data from our late-breaker presentation at the #livermtg19 @AASLDtweets @amirahalidrus www.fiercebiotech.com/biotech/aasld-vbi-vaccines-details-…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to present at the 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) on Friday, November 22, 2019 from 7:30PM-9:30PM MST in Phoenix www.vbivaccines.com/wire/gbm-part-b-data-sno-2019/ #glioblastoma #immunooncology
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) reports third quarter financial results and provides an update on the Company’s recent and future developments www.vbivaccines.com/wire/q3-2019-results-and-corporate-up…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to present new immuno-oncology data at the World Vaccine Congress Europe on Tuesday, October 29, 2019 at 5:15 PM CET in Barcelona www.vbivaccines.com/wire/wvce-2019/ #wvceu #vaccines
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces late-breaker poster presentation at the American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® on Monday, November 11, 2019 at 12:30 PM ET in Boston www.vbivaccines.com/wire/the-liver-meeting-2019-late-brea… #livermtg19 @AASLDtweets
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces late-breaker oral presentation at @IDWeek2019 on Friday, October 4, 2019 at 2:35 PM ET in Washington, D.C. www.vbivaccines.com/wire/idweek-2019-late-breaker-present… #idweek2019
-
VBI Vaccines Inc.
@VBIVaccines
VBIVaccines (Nasdaq: $VBIV) announces pricing of $35 Million public offering. The offering is expected to close on September 23, 2019 www.vbivaccines.com/press-releases/pricing-of-35-million-…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces a collaboration with GlaxoSmithKline (GSK) to clinically evaluate the combination of VBI-1901, VBI’s cancer vaccine immunotherapeutic, with GSK’s proprietary AS01B adjuvant system www.vbivaccines.com/wire/gsk-gbm-collaboration/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to present at the H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10, 2019, at 8:20 AM ET in New York www.vbivaccines.com/press-releases/hc-wainwright-2019/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) reports second quarter financial results and provides an update on the Company’s recent and future developments www.vbivaccines.com/wire/q2-2019-results-and-corporate-up…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019, at 1:30 PM ET in Boston, MA www.vbivaccines.com/wire/canaccord-genuity-39th-annual-gr…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) doses first patient in Part B of the ongoing Phase 1/2a clinical study of VBI-1901 in recurrent glioblastoma (GBM) patients www.vbivaccines.com/wire/dosing-of-first-recurrent-gbm-pa…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) has been added to the Russell 2000® and the Russell 3000® Indexes www.vbivaccines.com/wire/vbi-vaccines-added-to-russell-20…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: VBIV) to participate in an analyst-led fireside chat at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019, at 11:20 AM ET in New York City www.vbivaccines.com/wire/bmo-capital-markets-conference-2…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces positive top-line results from PROTECT, a pivotal Phase 3 study of Sci-B-Vac®. The company will hold a conference call and webcast at 8:00 AM ET this morning to review the data. www.vbivaccines.com/wire/vbi-vaccines-announces-positive-…
-
VBI Vaccines Inc.
@VBIVaccines
VBIVaccines (Nasdaq: $VBIV) is hosting a conference call and webcast tomorrow morning, June 17, 2019, at 8:00 AM ET to review PROTECT Phase 3 clinical data for Sci-B-Vac® www.vbivaccines.com/wire/conference-call-to-review-sci-b-…
-
VBI Vaccines Inc.
@VBIVaccines
David Anderson, Ph.D., of @VBIVaccines (Nasdaq: $VBIV) discussed safety, immunogenicity, and next steps for VBI’s ongoing Phase 1/2a study in recurrent GBM patients with OncologyTube at #asco19. Check out the interview here: oncologytube.com/video/vbi-1901-vaccine-two-different-com…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients @ASCO Annual Meeting www.vbivaccines.com/wire/vbi-1901-study-data-recurrent-gb… #asco19
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces Financial Results for the First Quarter Ending March 31, 2019, and Highlights Progress of the Company’s Pipeline www.vbivaccines.com/wire/q1-2019-results-and-corporate-up…
-
VBI Vaccines Inc.
@VBIVaccines
@Vbivaccines (Nasdaq: $VBIV) Provides Update on GBM Program and Announces a Conference Call and Webcast for Thursday, April 25, 2019 at 8:30 AM ET www.vbivaccines.com/wire/update-on-gbm-program-april-2019/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Welcomes Dr. Vlad Popovic as VP of Clinical Development and Medical Affairs www.vbivaccines.com/wire/vbi-vaccines-appoints-dr-vlad-po…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Welcomes Joanne Cordeiro, Former Chief Human Resources Officer and EVP of HR at Shire PLC, to its Board of Directors! www.vbivaccines.com/wire/vbi-vaccines-appoints-joanne-cor…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present a Late-Breaking Poster at The International Liver Congress (ILC), the Annual Meeting of the European Association for the Study of the Liver (EASL) to be Held in Vienna, Austria, April 10-14, 2019 www.vbivaccines.com/wire/late-breaking-poster-presentatio…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present Poster at the 7th International Congenital Cytomegalovirus (CMV) Conference & 17th International CMV Workshop Held April 7 – 11, 2019, in Birmingham, Alabama www.vbivaccines.com/wire/poster-presentation-7th-internat…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present at the Oppenheimer 29th Annual Healthcare Conference on Wednesday, March 20, 2019 at 9:10 AM ET in New York City www.vbivaccines.com/wire/oppenheimer-2019/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines Inc. (Nasdaq: $VBIV) Today Provided a Corporate Update, Outlook for 2019, and Announced its Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2018 www.vbivaccines.com/wire/2018-results-and-corporate-update/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces that the Independent Data and Safety Monitoring Board (DSMB) Completed its Third and Final Positive Safety Assessment of Part A of the Ongoing Phase 1/2a Clinical Study of VBI-1901 in Recurrent Glioblastoma Patients www.vbivaccines.com/wire/third-positive-dsmb-review-in-ph…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Appoints Dr. Blaine McKee, Executive Vice President and Chief Business Officer of ImmunoGen, Inc., to the Company’s Board of Directors
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) announces its plans for a Phase 2 clinical study evaluating VBI-1501, the company’s prophylactic cytomegalovirus (CMV) vaccine candidate, following positive discussions with Health Canada www.vbivaccines.com/wire/cmv-vaccines-phase-2-design/
-
VBI Vaccines Inc. reposted
Insira
@Insira_Global
Brii Bio in-licenses VBI Vaccines' VBI-2601 against Hepatitis B in China and other Asian countries for $128.5 million plus royalties
-
VBI Vaccines Inc. reposted
Briefing.com
@Briefingcom
$VBIV: VBI Vaccines enters into a license and collaboration agreement with Brii Biosciences for the development of a... www.briefing.com/in-depth-analysis/content/Article?Articl…
-
VBI Vaccines Inc. reposted
TheBiotechTimes
@BiotechTimes
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline xconomy.com/raleigh-durham/2018/12/06/brii-bios-alliance-…
-
VBI Vaccines Inc. reposted
Scrip, Citeline Commercial
@PharmaScrip
Brii Builds China Ops With Hep B Assets, New Partnerships
insights.citeline.com/SC124293/Brii-Builds-China-Ops-With… #pharmascrip -
VBI Vaccines Inc. reposted
Endpoints News
@endpts
Joining hunt for hep B cure, Brii Bio inks maiden deals featuring VBI, Vir, WuXi with a big appetite for more endpts.com/joining-hunt-for-hep-b-cure-brii-bio-inks-maid…
-
VBI Vaccines Inc. reposted
FierceBiotech
@FierceBiotech
Brii is handing over $11 million to VBI Vaccines—a $4 million upfront fee and a $7 million equity investment—in a license and collaboration agreement, but the latter could receive up to $117.5 million in milestones: www.fiercebiotech.com/biotech/brii-biosciences-ramps-up-v…
-
VBI Vaccines Inc. reposted
Frank Vinluan
@frankvinluan
China-focused Brii Bio partners with VBI #vaccines to develop potential #hepatitisb cure xconomy.com/raleigh-durham/2018/12/06/brii-bios-alliance-…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Enters into a $129 Million License and Collaboration Agreement with Brii Biosciences to Develop a Functional Cure for Chronic Hepatitis B Infection Using VBI’s Recombinant, Protein-Based Immuno-therapeutic, VBI-2601 www.vbivaccines.com/wire/vbi-agreement-with-brii-bio-to-d…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Today Announced Third Quarter 2018 Financial Results and Provided a Corporate Update www.vbivaccines.com/wire/q3-2018-results-and-corporate-up…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO) in New Orleans, Louisiana www.vbivaccines.com/wire/gbm-program-update-sno-2018/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Completes Vaccination in the PROTECT Phase 3 Clinical Study for Sci-B-Vac®, the Company’s Third-Generation Prophylactic Hepatitis B Vaccine www.vbivaccines.com/wire/vaccination-in-protect-phase-3-c…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces Late-Breaker Cytomegalovirus Abstract Has Been Selected for Oral Presentation at IDWeek 2018 in San Francisco, CA on October 6, 2018 at 11:10 AM PDT www.vbivaccines.com/wire/cmv-presentation-idweek-2018/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018 at 1:30 p.m. ET in New York City www.vbivaccines.com/wire/ladenburg-thalmann-2018/
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces the Formation of Three Scientific and Clinical Advisory Boards (SABs) Consisting of Leading Experts in Infectious Disease and Immuno-Oncology Research and Vaccine Development www.vbivaccines.com/wire/formation-of-new-scientific-and-…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces the Second Positive Data and Safety Monitoring Board (DSMB) Review of their Ongoing Phase 1/2a Clinical Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients www.vbivaccines.com/wire/second-dsmb-review-gbm-immunothe…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City on Thursday, September 6, 2018, at 12:05 PM ET www.vbivaccines.com/wire/rodman-renshaw-2018/
-
VBI Vaccines Inc.
@VBIVaccines
A New 3rd Generation Hepatitis B Vaccine Is Advancing Prevention Options www.futureofpersonalhealth.com/prevention-and-treatment/a…
-
VBI Vaccines Inc.
@VBIVaccines
@VBIVaccines (Nasdaq: $VBIV) Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine featured in @FiercePharma www.fiercepharma.com/vaccines/vbi-eyes-1b-cmv-vaccine-mar…
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 www.vbivaccines.com/wire/gbm-phase-1-2-a-study/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine www.vbivaccines.com/wire/sci-b-vac-phase-3-initiation/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Join us today for a presentation by CEO Jeff Baxter at the BMO Capital Markets Prescriptions for Success Healthcare Conference at 11:00 a.m. EST
You can access the webcast here: cc.talkpoint.com/bmoc001/121417a_as/?entity=38_GTRNEFD -
VBI Vaccines Inc.
@VBIVaccines
$VBIV Join us for a presentation by CEO Jeff Baxter at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday 12/14 at 11:00 a.m. EST
You can access the webcast here: cc.talkpoint.com/bmoc001/121417a_as/?entity=38_GTRNEFD -
VBI Vaccines Inc.
@VBIVaccines
$VBIV CEO Jeff Baxter is featured in @PharmaVOICE’s 2018 Year in Preview issue discussing how companies like ours contribute to the prevention of infectious diseases, by building awareness and developing innovative technologies. Read the full article here: www.pharmavoice.com/article/2017-11-wellness/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017 www.vbivaccines.com/wire/sitc-2017/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Strengthens Board of Directors with Appointment of Ran Nussbaum www.vbivaccines.com/wire/vbi-appoints-ran-nussbaum-to-bod/
-
VBI Vaccines Inc.
@VBIVaccines
#cmv awareness is vital for disease prevention. Check out @CMVAustralia's post and our site for more. #endcmvsilence www.vbivaccines.com/cmv/
CMV Association
@CMVAustralia
"CMV is the most common virus passed from mom to baby during a pregnancy, and this can happen to about 1-4% of... www.babygaga.com/12-things-that-affect-the-babys-appearan…
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares www.vbivaccines.com/wire/oct-2017-offering-closing/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Upsized Registered Direct Offering, Full Exercise of Underwriters’ Option for Add'l Shares, Total of $71.9M www.vbivaccines.com/wire/oct-2017-offering-upsized/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 Million www.vbivaccines.com/wire/oct-2017-offering-pricing/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares www.vbivaccines.com/wire/oct-2017-offering/
-
VBI Vaccines Inc.
@VBIVaccines
Wrapping up day 4 of the #livermtg17 at #aasld17; proud to be part of the community working toward eliminating #hbv @AASLDtweets
-
VBI Vaccines Inc.
@VBIVaccines
VBI's #hbv data is selected as a Presidential Poster of Distinction at #livermtg17 during #aasld17, be sure to stop by # 1865! @AASLDtweets
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Hepatitis B data has been selected as Presidential Poster of Distinction at The Liver Meeting during #aasld17 www.vbivaccines.com/wire/aasld-2017/
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV to Present at The World #vaccine Congress Europe 2017 in Barcelona #cmv #zika www.vbivaccines.com/wire/wvc-europe-2017/
-
VBI Vaccines Inc.
@VBIVaccines
Today $VBIV is presenting at the Ladenburg Thallman Healthcare Conference (2:30pm ET). Listen to the webcast here wsw.com/webcast/ladenburg3/register.aspx?conf=ladenburg3&…
-
VBI Vaccines Inc.
@VBIVaccines
Today $VBIV is presenting at the Cantor Fitzgerald Global Healthcare Conference (10:55am ET). Link to webcast here wsw.com/webcast/cantor6/register.aspx?conf=cantor6&page=v…
-
VBI Vaccines Inc.
@VBIVaccines
257 million people are currently living with #hbv, but this deadly infection can be prevented. Want to learn more? www.who.int/en/news-room/fact-sheets/detail/hepatitis-b
-
VBI Vaccines Inc.
@VBIVaccines
#cmv is the leading cause of birth defects in the US. Learn more about what VBI Vaccines is doing to #stopcmv here www.vbivaccines.com/cmv/
-
VBI Vaccines Inc. reposted
National CMV
@NationalCMV
Advocacy in action! To all CMV parents, family and friends - call your local media, demand interest, share facts. Together, we can #stopcmv
-
VBI Vaccines Inc.
@VBIVaccines
$VBIV Jeff Baxter on the Empowered Patient Podcast discusses #congenitalcmv #vaccine candidate #cmv #cmvawareness empoweredpatientradio.com/developing-vaccine-to-prevent-b…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: $VBIV) to Present at September 2017 Investor Conferences: www.vbivaccines.com/wire/september-2017-investor-events/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces FDA Acceptance of IND Application for Sci-B-Vac® Phase 3 Clinical Program: www.vbivaccines.com/wire/sci-b-vac-phase-3-fda-ind/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present New Preclinical Data for its #gbm Immunotherapy, VBI-1901, at the Immuno-Oncology Summit: www.vbivaccines.com/wire/io-summit-2017/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces FDA Acceptance of IND Application for VBI-1901 to Treat Glioblastoma Multiforme: www.vbivaccines.com/wire/gbm-program-fda-ind/
-
VBI Vaccines Inc.
@VBIVaccines
Today at 1:00 PM ET, join VBI for a conference call + webcast to discuss the CMV Vaccine Program interim data: public.viavid.com/index.php?id=125747
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines Announces Positive Interim Data from the Phase 1 Study of its Preventative CMV Vaccine: www.vbivaccines.com/wire/cmv-vaccine-interim-phase-1-stud…
-
VBI Vaccines Inc. reposted
FiercePharma
@FiercePharma
With eyes on Glaxo's Engerix-B vaccine, VBI takes hep B candidate into phase 3 www.fiercepharma.com/vaccines/targeting-gsk-s-engerix-b-v…
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI tomorrow at 8:30 AM ET for a conference call + webcast to discuss the Sci-B-Vac™ Phase 3 Clinical Program: public.viavid.com/index.php?id=125400
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces Phase 3 Clinical Program for Sci-B-Vac™ Hepatitis B Vaccine: www.vbivaccines.com/wire/sci-b-vac-phase-3-clinical-program/
-
VBI Vaccines Inc.
@VBIVaccines
VBI (Nasdaq: $VBIV) Added to the Russell 2000® and Russell 3000® Indexes: www.vbivaccines.com/wire/vbi-added-to-russell-indexes/ @FTSERussell #russell2000
-
VBI Vaccines Inc.
@VBIVaccines
VBI Reports Positive Phase III Pre-IND Meeting with the FDA for its Sci-B-Vac™ Hepatitis B Vaccine: www.vbivaccines.com/wire/sci-b-vac-fda-pre-ind-meeting/
-
VBI Vaccines Inc.
@VBIVaccines
Today at 12:30 PM ET - Join $VBIV for a live webcast at the Jefferies 2017 Global Healthcare Conference: wsw.com/webcast/jeff105/vbiv
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to Present at the Jefferies 2017 Global Healthcare Conference: www.vbivaccines.com/wire/jefferies-2017/
-
VBI Vaccines Inc. reposted
National CMV
@NationalCMV
June is National CMV Awareness Month! National CMV Awareness Month is a time to educate your community about... www.facebook.com/login/?next=https%3A%2F%2Fwww.facebook.c…
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore the Possible Link between #cmv Infection, Obesity, and Metabolic Syndrome: www.vbivaccines.com/wire/cmv-obesity-metabolic-syndrome/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Provides Update on its Congenital CMV Phase I Clinical Study: www.vbivaccines.com/wire/cmv-phase-i-clinical-study-updat…
-
VBI Vaccines Inc.
@VBIVaccines
One in ten pregnant women with #zika in the U.S. have babies with birth defects says new @CDCgov research: www.nytimes.com/2017/04/04/health/zika-birth-defects-unit…
-
VBI Vaccines Inc.
@VBIVaccines
The Rationale of Developing a More Immunogenic Hepatitis B Vaccine for Healthcare Workers: www.vbivaccines.com/wire/healthcare-workers-hbv-infection/
-
VBI Vaccines Inc.
@VBIVaccines
Download VBI’s World Vaccine Congress presentations for updates on Sci-B-Vac™ and our GBM Immunotherapy Program: www.vbivaccines.com/wire/wvc-2017
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Assess Outcomes Following Passage of Utah #cmv Legislation: www.vbivaccines.com/wire/utah-cmv-legislation-outcomes/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present Updates on Multiple Programs at the World Vaccine Congress: www.vbivaccines.com/wire/wvc-2017/ #wvcusa
-
VBI Vaccines Inc.
@VBIVaccines
VBI Appoints Avi Mazaltov as Global Head of Manufacturing and SciVac General Manager: www.vbivaccines.com/wire/avi-mazaltov-appointed-global-he…
-
VBI Vaccines Inc. reposted
National CMV
@NationalCMV
It's official--CMV legislation becomes law in Idaho!... www.idahopress.com/news/otter-signs-cmv-bill-into-law/art…
-
VBI Vaccines Inc.
@VBIVaccines
Research suggests that improved hepatitis B vaccine options for persons with #esrd may be beneficial: www.vbivaccines.com/wire/esrd-hbv-infection/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Receives Positive Initial Response from Health Canada Regarding the Sci-B-Vac™ Phase III Clinical Study: www.vbivaccines.com/wire/sci-b-vac-phase-3-study-health-c…
-
VBI Vaccines Inc.
@VBIVaccines
EMA Committee Rules Favorably on VBI Vaccine for Hepatitis B [via Hepatitis News Today]: hepatitisnewstoday.com/2017/02/14/vbi-vaccines-receives-p…
-
VBI Vaccines Inc.
@VBIVaccines
VBI is proud to announce its sponsorship support of Le Classique, an annual fundraiser supporting #cmv awareness: globalnews.ca/news/3242637/fifth-annual-le-classique-fund…
-
VBI Vaccines Inc.
@VBIVaccines
Research suggests that improved hepatitis B vaccine options for persons with #diabetes may be beneficial: www.vbivaccines.com/wire/diabetes-hbv-infection/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Receives Positive EMA Scientific Advice Regarding Sci-B-Vac™ Phase III Clinical Study: www.vbivaccines.com/wire/sci-b-vac-phase-3-study-ema-advice/
-
VBI Vaccines Inc.
@VBIVaccines
A new study suggests a possible link between congenital #cmv infection and ALL, a common childhood cancer: www.vbivaccines.com/wire/cmv-all-link/
-
VBI Vaccines Inc.
@VBIVaccines
Some emerging evidence suggests that #zika infection may lead to male reproductive tract damage and infertility: www.vbivaccines.com/wire/zika-virus-2017/
-
VBI Vaccines Inc.
@VBIVaccines
What's new with #zika? Zika continues to spread and there have been a number of important discoveries: www.vbivaccines.com/wire/zika-virus-2017/
-
VBI Vaccines Inc.
@VBIVaccines
Hepatitis B vaccine failure is often explained by the gradual deterioration of the aging immune system: www.vbivaccines.com/wire/elderly-hbv-infection/ #hbv
-
VBI Vaccines Inc. reposted
National CMV
@NationalCMV
CMV expert Dr. Gail Harrison counters ACOG's prevention policy reversal: www.medscape.com/viewarticle/872452 #stopcmv #cmvawareness @acognews @cdcgov
-
VBI Vaccines Inc.
@VBIVaccines
VBI (Nasdaq: $VBIV) Closes $23.6 Million Financing from Perceptive Advisors: www.vbivaccines.com/wire/23-million-financing/
-
VBI Vaccines Inc.
@VBIVaccines
Dr. David A. Reardon, M.D @DanaFarber discusses the need for a new standard of care in the treatment of #gbm: www.onclive.com/view/dr-reardon-on-the-need-for-a-new-sta…
-
VBI Vaccines Inc.
@VBIVaccines
In this spirit of giving thanks this holiday season, we celebrate Louis Pasteur, a 19th century vaccine pioneer: www.vbivaccines.com/wire/louis-pasteur-attenuated-vaccine/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Reports Rapid Seroprotection from an Interim Analysis of a Phase IV Study of its Sci-B-Vac™ Hepatitis B Vaccine: www.vbivaccines.com/wire/sci-b-vac-phase-iv-interim-results/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Society of Neuro-Oncology Annual Meeting: www.vbivaccines.com/wire/sno-2016/ @NeuroOnc
-
VBI Vaccines Inc.
@VBIVaccines
Memory Inflation as a Doorway to Sustained Immune Response: www.vbivaccines.com/wire/cmv-memory-inflation/ #cancer #immunotherapy
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present #zika Vaccine Program Poster at the Keystone Symposia on Translational Vaccinology for Global Health: www.vbivaccines.com/wire/keystone-2016-london/
-
VBI Vaccines Inc. reposted
Catherine SaintLouis
@cslwrites
Few pregnant women are warned about CMV, which can cause microcephaly, stillbirth, deafness. Why? www.nytimes.com/2016/10/25/health/cmv-cytomegalovirus-pre…
-
VBI Vaccines Inc.
@VBIVaccines
The Rationale for Developing a More Immunogenic Hepatitis B Vaccine: www.vbivaccines.com/wire/the-rationale-for-developing-a-m… #hbv
-
VBI Vaccines Inc. reposted
Jeff Brown
@jeffbrownwbz
Cambridge based @VBIVaccines hopes to file with #fda on new drug application next yr for glioblastoma treatment. #nebiz
-
VBI Vaccines Inc.
@VBIVaccines
VBI Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate: www.vbivaccines.com/wire/pre-ind-meeting-gbm-candidate/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the World Vaccine Congress Europe: www.vbivaccines.com/wire/wvc-europe-2016/
-
VBI Vaccines Inc.
@VBIVaccines
Today at 10:00 AM ET - Join $VBIV for a live webcast at the Ladenburg Thalmann Healthcare Conference: wsw.com/webcast/ladenburg2/vbiv
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Ladenburg Thalmann Healthcare Conference: www.vbivaccines.com/wire/ladenburg-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Completes Enrollment of Participants in the Phase I Clinical Trial of its Preventative CMV Vaccine Candidate: www.vbivaccines.com/wire/cmv-phase-1-enrollment-complete/
-
VBI Vaccines Inc.
@VBIVaccines
Today at 4:15 PM ET - Join $VBIV at the Rodman and Renshaw Global Investment Conference: www.vbivaccines.com/wire/rodman-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Rodman & Renshaw Annual Global Investment Conference: www.vbivaccines.com/wire/rodman-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the 10th Vaccine Congress: www.vbivaccines.com/wire/tenth-vaccine-congress/ @vaccinecongress
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Immuno-Oncology Summit: www.vbivaccines.com/wire/io-summit/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Continue Enrolling Participants in the Phase I Trial of its CMV Vaccine Candidate Following DSMB Review: www.vbivaccines.com/wire/cmv-study-dsmb-review/
-
VBI Vaccines Inc.
@VBIVaccines
Exploring the background and history of the #zika virus: www.vbivaccines.com/wire/zika-background-history/
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore Possible Link Between #cmv and #alzheimer’s Disease: www.vbivaccines.com/wire/cmv-and-alzheimers-disease/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer: www.vbivaccines.com/wire/diaz-mitoma-cmo/
-
VBI Vaccines Inc. reposted
Nasdaq Exchange
@NasdaqExchange
Watch @VBIVaccines ring the @Nasdaq Opening Bell! $VBIV
-
VBI Vaccines Inc. reposted
Nasdaq Exchange
@NasdaqExchange
.@VBIVaccines rings the @Nasdaq Opening Bell!
-
VBI Vaccines Inc.
@VBIVaccines
VBI Applies its eVLP Platform in the Development of a #zika Vaccine Candidate: www.vbivaccines.com/wire/zika-vaccine-candidate/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: $VBIV) to Ring the Nasdaq Stock Market Opening Bell on Wednesday, July 20: www.vbivaccines.com/wire/nasdaq-opening-bell/
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore the Mechanisms by Which #cmv Infection May Impact Fetal Brain Development: www.vbivaccines.com/wire/cmv-infection-fetal-brain-develo…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines (Nasdaq: $VBIV) Added to the Russell Microcap® Index @FTSERussell #russellrecon
-
VBI Vaccines Inc.
@VBIVaccines
VBI begins enrolling participants in a Phase I trial of its preventative #cmv vaccine candidate: www.vbivaccines.com/wire/cmv-program-phase-1-trial/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines announces the closing of a $13.6M private placement led by OPKO Health ($OPK) and Perceptive Advisors: www.vbivaccines.com/wire/private-placement-2016/
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI at the Virus-Like Particle and Nano-Particle Vaccines Conference on Friday, June 24: www.vbivaccines.com/wire/vlpnpv-2016/ #vlpnpv2016
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines Announces #medulloblastoma Immunotherapy Program: www.vbivaccines.com/wire/medulloblastoma-immunotherapy-ca…
-
VBI Vaccines Inc.
@VBIVaccines
Today at 12:00 PM ET, watch a live webcast of our Hepatitis B KOL Meeting: lifesci.rampard.com/20160613/reg.jsp
-
VBI Vaccines Inc.
@VBIVaccines
Today at 2:30 PM ET - Join $VBIV for a live webcast at the #jefferies Healthcare Conference: wsw.com/webcast/jeff97/vbiv
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI on June 13 to discuss new approaches to vaccination against hepatitis B as well as the unmet medical need: www.vbivaccines.com/wire/hbv-kol-meeting/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to present at the BIO International Convention on Monday, June 6 at 3:30 PM ET (12:30 PM PT): www.vbivaccines.com/wire/bio-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to Present at the #jefferies Healthcare Conference: www.vbivaccines.com/wire/jefferies-2016/
-
VBI Vaccines Inc.
@VBIVaccines
SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction: www.vbivaccines.com/wire/scivac-merger/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Bloom Burton Healthcare Investor Conference on Monday, May 2nd at 1:30 PM ET: www.vbivaccines.com/wire/bloom-burton-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI and SciVac Therapeutics Announce Effectiveness of Registration Statement on Form F-4: www.vbivaccines.com/wire/f4-registration-effective/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to share new data at #wvcusa that supports the use of eVLP vaccines in combination with checkpoint inhibitors: www.vbivaccines.com/wire/wvc-2016/
-
VBI Vaccines Inc. reposted
NRC Canada
@NRC_CNRC
NRC helped @VBIVaccines vaccines inject hope into battle against #cmvvirus nrc.canada.ca/en
-
VBI Vaccines Inc.
@VBIVaccines
Iowa Lawmaker Introduces Congenital #cmv Screening and Education Legislation: www.vbivaccines.com/wire/iowa-cmv-legislation/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Presents New Data Supporting its GBM Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference: www.vbivaccines.com/wire/keystone-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI's Jeff Baxter to Present at the ROTH Conference on Tuesday, March 15th at 5:30 PM PT (8:30 PM ET): www.vbivaccines.com/wire/roth-2016/
-
VBI Vaccines Inc. reposted
GSK
@GSK
Pleased to work with @VBIVaccines on an innovative approach to improve stability of our vaccines #leadingscience gsk.to/20Vomt7
-
VBI Vaccines Inc.
@VBIVaccines
A Fox News affiliate shares the story of Anna Leigh Duncan, who's daughter was born congenitally infected with CMV: www.fox13news.com/health/88508691-story
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability: www.vbivaccines.com/wire/vbi-gsk-research-collaboration/
-
VBI Vaccines Inc.
@VBIVaccines
VBI partners with the Canadian CMV Foundation to raise congenital #cytomegalovirus awareness: www.vbivaccines.com/wire/le-classique-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to Present at the BIO CEO and Investor Conference: www.vbivaccines.com/wire/bioceo-2016/ #bioceo16
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore Possible Link between #cytomegalovirus and Breast Cancer: www.vbivaccines.com/wire/cmv-and-breast-cancer/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the Noble Financial Emerging Growth Investor Conference on Monday, January 18th at 10:00 AM ET: www.vbivaccines.com/wire/noblecon-2016/
-
VBI Vaccines Inc.
@VBIVaccines
VBI takes an in-depth look at the role of #neoantigens in cancer immunotherapy: www.vbivaccines.com/wire/neoantigens-in-cancer-immunother…
-
VBI Vaccines Inc.
@VBIVaccines
In this spirit of giving thanks this holiday season, we celebrate Edward Jenner, a pioneering vaccine researcher: www.vbivaccines.com/wire/edward-jenner-and-the-first-mode…
-
VBI Vaccines Inc.
@VBIVaccines
Maddie's Mission, Stop CMV, and the Utah CMV Council have combined to form a broad reaching National CMV Foundation: www.nationalcmv.org
-
VBI Vaccines Inc.
@VBIVaccines
VBI's Jeff Baxter to Present at the LD Micro Conference on Thursday, December 3rd at 1:30 PM ET (10:30 AM PT): www.vbivaccines.com/conferences/ld-mirco-2015/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Presents New Data Supporting its #glioblastoma #immunotherapy Program at the #esmo Symposium on Immuno-Oncology: www.vbivaccines.com/wire/esmo-2015/
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Examine CMV Antigens in Novel #glioblastoma Immunotherapies: www.vbivaccines.com/wire/cmv-antigens-gbm-immunotherapy/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present Update and New Data Supporting its #rsv and #cmv Vaccine Programs at the World Vaccine Congress: www.vbivaccines.com/wire/wvce-2015/
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI and SciVac on Nov 5th at 3:00 PM ET for a live webcast and conference call to discuss the proposed merger: www.vbivaccines.com/wire/merger-webcast/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines and SciVac Therapeutics to Hold Joint Conference Call for Shareholders to Discuss Proposed Merger: www.vbivaccines.com/wire/merger-conference-call/
-
VBI Vaccines Inc.
@VBIVaccines
New Research Highlights Possible Link between Congenital #cmv and Vestibular Disorders: www.vbivaccines.com/wire/cmv-and-vestibular-disorders/
-
VBI Vaccines Inc.
@VBIVaccines
SciVac Therapeutics Enters into Agreement to Acquire VBI Vaccines: www.vbivaccines.com/wire/vbi-scivac-merger-agreement/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines Announces Development of a Novel #glioblastoma Immunotherapy Candidate: www.vbivaccines.com/wire/gbm-immunotherapy-candidate/
-
VBI Vaccines Inc.
@VBIVaccines
U.N. Officials Take Steps to Rebuild Vaccine Cold Chain in War-Torn South Sudan: www.vbivaccines.com/wire/south-sudan-cold-chain/ #southsudan
-
VBI Vaccines Inc.
@VBIVaccines
VBI to present and participate in a vaccines panel discussion at the 15th Annual Biotech in Europe Forum: www.vbivaccines.com/wire/biotech-in-europe-forum-2015/
-
VBI Vaccines Inc.
@VBIVaccines
Respiratory syncytial virus ("RSV") infection in elderly and high-risk adults: www.vbivaccines.com/wire/rsv-infection-in-elderly-and-hig…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Promotes Dr. David E. Anderson to Chief Scientific Officer: www.vbivaccines.com/wire/dr-david-anderson-chief-scientif…
-
VBI Vaccines Inc.
@VBIVaccines
Respiratory syncytial virus (“RSV”) is a leading cause of serious disease in infants and young children globally: www.vbivaccines.com/wire/rsv-infection-in-infants-and-you…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Awarded NRC-IRAP Funding to Leverage its eVLP Platform in the Development of a Novel RSV Vaccine Candidate: www.vbivaccines.com/wire/rsv-funding/
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI Vaccines for a live webcast at the Rodman & Renshaw 17th Annual Global Investment Conference on Sept 10th: www.vbivaccines.com/wire/rodman-2015/
-
VBI Vaccines Inc.
@VBIVaccines
New Texas state law to have public education program for CMV: www.chron.com/neighborhood/katy/news/article/New-state-la…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to Provide an Update on its #cmv Vaccine Program at the Tenth Annual IMVACS Summit: www.vbivaccines.com/wire/imvacs-2015/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines Announces Closing of $6.29 Million Private Placement: www.vbivaccines.com/wire/private-placement-august-2015/
-
VBI Vaccines Inc. reposted
Denver Broncos
@Broncos
#broncos scout John Spytek and his wife Kristen had never heard of Cytomegalovirus (CMV) dbron.co/78l
-
VBI Vaccines Inc.
@VBIVaccines
Congenital #cmv Charitable Organizations Lead the Way in Raising Condition Awareness: www.vbivaccines.com/wire/cmv-charities/ #cmvawareness
-
VBI Vaccines Inc.
@VBIVaccines
Three U.S. States Enact Legislation to Combat Congenital #cmv in 2015: www.vbivaccines.com/cytomegalovirus-cmv/three-states-enac…
-
VBI Vaccines Inc. reposted
UNICEF Pakistan
@UNICEF_Pakistan
The process is called ‘cold-chain’: facilities, trucks & handheld coolers must have a steady temperature. A 1˚C deviation can spoil vaccine.
-
VBI Vaccines Inc.
@VBIVaccines
VBI Vaccines to Present at the 2015 BIO International Convention on Wednesday, June 17th at 11:30 AM ET: www.vbivaccines.com/wire/bio-2015/ #bio2015
-
VBI Vaccines Inc.
@VBIVaccines
Surveying the Impact of Accidental Freezing in the Vaccine Cold Chain: www.vbivaccines.com/wire/freezing-cold-chain/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Presents Data Supporting the Potential Use of Its eVLP Platform in the Development of a Novel HCV Vaccine: www.vbivaccines.com/wire/wvc-asia-2015/
-
VBI Vaccines Inc.
@VBIVaccines
CT Governor Dan Malloy Signs CMV Bill into Law: foxct.com/2015/05/27/new-law-in-connecticut-to-fight-numb…
-
VBI Vaccines Inc.
@VBIVaccines
Connecticut Law Requiring #cmv Testing for Newborns with Hearing Loss Awaits Governor's Approval: www.vbivaccines.com/wire/ct-cmv-law/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Discuss the Manufacture of Enveloped Virus-like Particles at the #mvads Conference: www.vbivaccines.com/wire/mvads-2015/
-
VBI Vaccines Inc.
@VBIVaccines
Failure of the “cold chain” is suspected in the death of a six-year-old girl who was bitten by a rabid dog: www.vbivaccines.com/wire/rabies-vaccine-cold-chain-failure/
-
VBI Vaccines Inc. reposted
World Health Organization (WHO)
@WHO
WHO has stepped up efforts to support immunization progs in #yemen & provided fuel needed for generators to maintain the vaccine cold chain
-
VBI Vaccines Inc.
@VBIVaccines
U.S. States Considering Congenital #cmv Legislation in 2015: www.vbivaccines.com/wire/cmv-legislation-2015/ #endcmvsilence
-
VBI Vaccines Inc. reposted
CMV Action UK
@cmvactionuk
#cmv in the News: @VBIVaccines reported on the recent progress of its CMV vaccine candidate last week.
VBI Vaccines Inc.
@VBIVaccines
VBI Announces New Data Supporting the Manufacture of its Prophylactic #cmv Vaccine Candidate: www.vbivaccines.com/wire/cmv-vaccine-update-wvc-2015/
-
VBI Vaccines Inc. reposted
NFID
@NFIDVaccines
.@VBIVaccines & @sanofipasteur to collaborate on #vaccine R&D www.biopharmadive.com/news/vbi-vaccines-sanofi-pasteur-to… via @biopharmadive
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces New Data Supporting the Manufacture of its Prophylactic #cmv Vaccine Candidate: www.vbivaccines.com/wire/cmv-vaccine-update-wvc-2015/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces Research Collaboration with Sanofi Pasteur to Enhance Vaccine Stability: www.vbivaccines.com/wire/sanofi-pasteur-collaboration/
-
VBI Vaccines Inc.
@VBIVaccines
New Research Explores a Mechanism by which Congenital #cmv Infection May Disrupt Fetal Development: www.vbivaccines.com/wire/cmv-and-fetal-development/
-
VBI Vaccines Inc.
@VBIVaccines
Heat Degradation Blamed for Reduced H1N1 Vaccine Potency: www.vbivaccines.com/wire/heat-degradation-blamed-for-redu…
-
VBI Vaccines Inc.
@VBIVaccines
Emory Vaccine Center celebrates VBI advisor Stanley Plotkin for his pioneering work in researching #cmv: link.springer.com/article/10.1007/s00430-015-0392-3
-
VBI Vaccines Inc.
@VBIVaccines
Postnatal CMV Infection in Premature Infants: www.vbivaccines.com/wire/postnatal-cmv-infection-in-prema…
-
VBI Vaccines Inc.
@VBIVaccines
Dr. Brenda Balch Shares CMV Prevention Strategies with ABC Affiliate Station [Video]: www.vbivaccines.com/wire/cmv-prevention-strategies-video/
-
VBI Vaccines Inc.
@VBIVaccines
Check out our photos from the End CMV Silence Gala held this past February at the Utah State Capitol Building: www.facebook.com/media/set/
-
VBI Vaccines Inc. reposted
Pharmaceutical Commerce
@PharmaCommerce
Almost a third of newly approved drugs are cold chain products www.pharmaceuticalcommerce.com?pg=top_news&articleid=2743… #pharma
-
VBI Vaccines Inc.
@VBIVaccines
Hawaii Moves to Establish CMV Public Education Program: www.vbivaccines.com/wire/hawaii-cmv-legislation/ #cmv
-
VBI Vaccines Inc. reposted
BCMHouston
@bcmhouston
Join @Maddies_Mission to raise awareness for cytomegalovirus and support Baylor research: blogs.bcm.edu/2015/02/12/cytomegalovirus-what-you-should-….
-
VBI Vaccines Inc. reposted
MedCision
@MedCisionLLC
Low Measles Vaccine Immunogenicity Linked to Cold Chain Disruptions blog.biocision.com?p=11627
-
VBI Vaccines Inc.
@VBIVaccines
Cold Chain Failures Cited in Study Examining Poor Measles Vaccine Potency: www.vbivaccines.com/wire/cold-chain-measles-potency/ #coldchain
-
VBI Vaccines Inc.
@VBIVaccines
Check out our photos from Le Classique, a Winnipeg-based event promoting CMV awareness in Canada: www.facebook.com/vbivaccines/photos
-
VBI Vaccines Inc.
@VBIVaccines
CDC Evaluates the Effectiveness of New CMV Education Materials: www.vbivaccines.com/wire/cdc-evaluates-cmv-education-mate…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Partners with the Utah CMV Council to Raise CMV Awareness: www.vbivaccines.com/wire/vbi-partners-with-the-utah-cmv-c… @UtahCMVCouncil #cmv
-
VBI Vaccines Inc. reposted
Disabled World (DW) Disability News Service
@DisabledWorld
#cytomegalovirus Education and Awareness Research #grants - #cmv #disabledworld -- www.disabled-world.com/disability/awareness/cmv.php
-
VBI Vaccines Inc. reposted
IsaacHoleman
@isaacholeman
The art of saving a life justifies my research with fun cartoons-an animated intro to vaccine cold chain! cc @Nexleaf artofsavingalife.com/artists/christoph-niemann/
-
VBI Vaccines Inc.
@VBIVaccines
Exploring Alternatives to the Cold Chain Delivery System in China: www.vbivaccines.com/wire/china-cold-chain/
-
VBI Vaccines Inc.
@VBIVaccines
New Twin Study Suggests that CMV Plays a Key Role in Shaping the Immune System: www.vbivaccines.com/wire/cmv-twin-study/ #cmv #cytomegalovirus
-
VBI Vaccines Inc.
@VBIVaccines
New Study Lends Support to Possible CMV-Glioblastoma Connection: www.vbivaccines.com/wire/cmv-gbm-new-research/
-
VBI Vaccines Inc.
@VBIVaccines
VBI's Jeff Baxter will present at the Noble Conference today at 2:30 PM ET. View the live webcast here: www.vbivaccines.com/wire/vbi-at-noble-financial-2015/
-
VBI Vaccines Inc.
@VBIVaccines
Vaccine Storage Guidelines Underscore the Challenges of Cold Chain Maintenance: www.vbivaccines.com/wire/vaccine-cold-storage-guidelines/
-
VBI Vaccines Inc.
@VBIVaccines
VBI's Jeff Baxter Interviewed by Henry Truc at the Small-Cap Stars Conference [Video]: www.vbivaccines.com/wire/jeff-baxter-equities-interview/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Partners with Le Classique to Raise CMV Awareness in Canada: www.vbivaccines.com/wire/le-classique-cmv-canada/ #cmv
-
VBI Vaccines Inc.
@VBIVaccines
Watch VBI Present at the Noble Financial Capital Markets Equity Conference on January 20th: www.vbivaccines.com/wire/vbi-at-noble-financial-2015/
-
VBI Vaccines Inc. reposted
NK papers
@NK_papers
Natural Killer Cells can Inhibit the Transmission of Human Cytomegalovirus in Cell Culture Using Mechanisms from... www.ncbi.nlm.nih.gov/pubmed/25540381?dopt=Abstract
-
VBI Vaccines Inc.
@VBIVaccines
A recent study monitored CMV shedding patterns in healthy CMV-seropositive children: www.vbivaccines.com/wire/cmv-shedding-in-healthy-cmv-posi…
-
VBI Vaccines Inc. reposted
Maddie's Mission
@Maddies_Mission
Learn about #cytomegalovirus from top ID Doc Demmler-Harrison!www.texaschildrensblog.org/2014/12/cmv-in-pregnancy-what-…
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Investigate Possible Link between CMV Infection and Atherosclerosis: www.vbivaccines.com/wire/cmv-atherosclerosis-research/
-
VBI Vaccines Inc.
@VBIVaccines
Thermostable Vaccine Contributes to the Reduction of Meningitis A in Africa: www.vbivaccines.com/wire/menafrivac-thermostable-vaccine/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the equities.com Small-Cap Stars Conference on December 18th: www.vbivaccines.com/wire/small-cap-stars-conference/
-
VBI Vaccines Inc.
@VBIVaccines
Join VBI for a Live Webcast on Wednesday, December 3rd at 12:00 PM ET: www.vbivaccines.com/wire/ld-micro-webcast/
-
VBI Vaccines Inc.
@VBIVaccines
VBI will present at the LD Micro Conference on December 3rd at 9 AM PT. The event is being held in Los Angeles, CA: www.vbivaccines.com/wire/ld-micro-conference/
-
VBI Vaccines Inc.
@VBIVaccines
New Study Explores Breast Milk as Postnatal CMV Transmission Source in Very Low Birth Weight Infants: www.vbivaccines.com/wire/breast-milk-as-postnatal-cmv-tra…
-
VBI Vaccines Inc.
@VBIVaccines
Congenital CMV Webinar [Video]: www.vbivaccines.com/wire/congenital-cmv-101/
-
VBI Vaccines Inc.
@VBIVaccines
VBI Reports Q3 2014 Financial Results and Provides Update on CMV Vaccine Development Program: www.vbivaccines.com/wire/q3-2014-results/
-
VBI Vaccines Inc.
@VBIVaccines
CMV is among the most common infections following solid-organ transplantation: www.vbivaccines.com/wire/cmv-organ-transplant-market-over…
-
VBI Vaccines Inc.
@VBIVaccines
VBI's Adam Buckley will be attending BIO-Europe this week: www.vbivaccines.com/wire/vbi-at-bio-europe/ #bioeurope
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore Impact of CMV on Aging and the Immune System with NIH Support: www.vbivaccines.com/wire/cmv-immune-system-aging/
-
VBI Vaccines Inc.
@VBIVaccines
Universal CMV Screening of Newborns Faces Systemic Challenges: www.vbivaccines.com/wire/universal-cmv-screening-of-newbo…
-
VBI Vaccines Inc.
@VBIVaccines
Researchers Explore Possible Link between CMV and Glioblastoma (GBM): www.vbivaccines.com/wire/cmv-gbm-research/
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the 14th Annual Biotech in Europe Investor Forum: www.vbivaccines.com/wire/vbi-to-present-at-the-sachs-asso…
-
VBI Vaccines Inc.
@VBIVaccines
Utah was the first state to pass legislation designed to improve CMV awareness and screening for those most at risk: www.vbivaccines.com/wire/utah-leads-the-u-s-in-cmv-screen…
-
VBI Vaccines Inc.
@VBIVaccines
VBI has been invited to speak at the CMV Public Health & Policy Conference: www.vbivaccines.com/wire/vbi-to-present-at-the-cmv-public…
-
VBI Vaccines Inc.
@VBIVaccines
VBI's thermostable technology could increase vaccine safety, efficacy, and access: www.vbivaccines.com/wire/thermostable-vaccines-overview-a…
-
VBI Vaccines Inc.
@VBIVaccines
New Data Supporting VBI's Prophylactic CMV Vaccine Candidate (VBI-1501A) Presented at the ICAAC Conference: www.vbivaccines.com/wire/new-cmv-data-presented-at-icaac/
-
VBI Vaccines Inc.
@VBIVaccines
Despite its prevalence, awareness of Congenital CMV among women of reproductive age remains low: www.vbivaccines.com/wire/cmv-awareness-lags-prevalence/
-
VBI Vaccines Inc.
@VBIVaccines
Join Dr. Michael Cannon, a CDC epidemiologist, for a webcast discussing congenital CMV this Thursday at 1:30PM ET: www.vbivaccines.com/wire/dr-michael-cannon-cdc-webinar/
-
VBI Vaccines Inc.
@VBIVaccines
Houston Congenital CMV Study Spans 32 Years: www.vbivaccines.com/wire/houston-congenital-cmv-study-spa…
-
VBI Vaccines Inc.
@VBIVaccines
VBI’s CMV Vaccine Candidate Design and Preclinical Data [Video]: www.vbivaccines.com/wire/cmv-vaccine-design-preclinical-d…
-
VBI Vaccines Inc.
@VBIVaccines
eVLPs and The Evolution of Virus-Like Particle Vaccine Technology [Video]: www.vbivaccines.com/wire/virus-like-particle-vaccine-hist…
-
VBI Vaccines Inc.
@VBIVaccines
VBI and Paulson Capital Announce Completion of Merger: www.vbivaccines.com/wire/vbi-and-paulson-capital-announce…
-
VBI Vaccines Inc.
@VBIVaccines
VBI to Present at the CMV Public Health Conference in Salt Lake City, UT on September 26th and 27th 2014: www.vbivaccines.com/wire/cmv-conference-utah/
-
VBI Vaccines Inc.
@VBIVaccines
Paulson Capital and VBI Enter Into Merger Agreement: www.vbivaccines.com/wire/paulson-capital-and-vbi-enter-in…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Begins GMP Tech Transfer to Paragon Bioservices: www.vbivaccines.com/wire/vbi-begins-gmp-tech-transfer-to-…
-
VBI Vaccines Inc.
@VBIVaccines
VBI’s eVLP-based CMV Vaccine Published in Clinical and Vaccine Immunology: www.vbivaccines.com/wire/vbis-evlp-based-cmv-vaccine-publ…
-
VBI Vaccines Inc.
@VBIVaccines
[Boston Business Journal] VBI Vaccines Pulls In $2.2M Debt Round: www.bizjournals.com/boston/blog/mass-high-tech/2012/02/vb…
-
VBI Vaccines Inc.
@VBIVaccines
VBI Announces Acquisition of Epixis and Its Innovative eVLP Vaccine Platform: www.vbivaccines.com/wire/vbi-announces-acquisition-of-epi…
-
VBI Vaccines Inc.
@VBIVaccines
[Genetic Engineering and Biotechnology News] VBI Acquires Epixis for VLP Vaccines Capabilities: www.genengnews.com/topics/drug-discovery/vbi-acquires-epi…
-
VBI Vaccines Inc.
@VBIVaccines
[Fierce Vaccines] VBI buys Epixis, Gains CMV, Hep C Vaccines: www.fiercevaccines.com/story/vbi-buys-epixis-gains-cmv-he…
-
VBI Vaccines Inc.
@VBIVaccines
[Boston Business Journal] Variation Biotech Taps Backers for $7.8M in Debt Funding: www.bizjournals.com/boston/blog/mass-high-tech/2011/07/va…
-
VBI Vaccines Inc.
@VBIVaccines
[xconomy] VBI Progressing with Vaccines That Don’t Require Refrigeration: www.bioxconomy.com/boston/2011/03/24/vbi-progressing-with…











































































































































































